Molecular platform for oncology and infectious diseases
The MDx Idylla platform from Biocartis is a fully automated sample-to-result, real-time polymerase chain reaction (PCR) system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting.
Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent the fastest growing and largest segments, respectively, of the MDx market worldwide. Today, Biocartis has 10 oncology tests and two infectious disease tests on the market.